Cancer Stem Cell News Volume 4.42 | Nov 4 2015

    Cancer Stem Cell News 4.42 November 4, 2015

    Cancer Stem Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  CSCN on Twitter

    HIF-1 Regulates CD47 Expression in Breast Cancer Cells to Promote Evasion of Phagocytosis and Maintenance of Cancer Stem Cells
    Investigators report that hypoxia-inducible factor 1 (HIF-1) directly activates transcription of the CD47 gene in hypoxic breast cancer cells. CD47 expression was increased in mammosphere cultures, which are enriched for cancer stem cells, and CD47 deficiency led to cancer stem cell depletion. [Proc Natl Acad Sci USA] Abstract
    Enter now to win a $500 travel award to attend the Annual American Society for Hematology (ASH) Meeting in Orlando, Florida!

    PUBLICATIONS (Ranked by impact factor of the journal)
    Identification of CD146 as a Marker Enriched for Tumor-Propagating Capacity Reveals Targetable Pathways in Primary Human Sarcoma
    Scientists performed a high-throughput cell surface antigen screen and found that CD146 is enriched in the tumor side population. In vivo serial transplantation assays showed that CD146+ cells are highly tumorigenic, capable of self-renewal and thus enriches the tumor-propagating cells population. [Oncotarget] Full Article

    Targeting Stemness Is an Effective Strategy to Control EML4-ALK+ Non-Small Cell Lung Cancer Cells
    The authors report that stem-like properties stem from anaplastic lymphoma kinase (ALK) activity in echinoderm microtubule-associated protein-like 4 (EML4)-ALK+ non-small cell lung carcinoma cells. [Oncotarget] Full Article

    Bub1 Is Required for Maintaining Cancer Stem Cells in Breast Cancer Cell Lines
    Scientists identified that depleting Bub1 (budding uninhibited by benzimidazoles 1) using shRNAs reduces cancer stem cell potential of the MDA-MB-231 breast cancer cell line, resulting in inhibited formation of xenografts in immunocompromised mice. [Sci Rep] Full Article

    A Paired Comparison between Glioblastoma ‘Stem Cells’ and Differentiated Cells
    Researchers compared key features of three pairs of glioblastoma cell populations, each pair consisting of stem cell-like and differentiated cells derived from an individual patient. [Int J Cancer] Abstract

    Tumor Cell-Derived Periostin Regulates Cytokines that Maintain Breast Cancer Stem Cells
    Scientists hypothesized that basal-like breast cancer (BLBC) cells are able to establish a niche permissive to the maintenance of cancer stem cells (CSCs) and found that tumor cell-derived periostin, a component of the extracellular matrix, as well as a corresponding cognate receptor, integrin alphavbeta3, are highly expressed in a subset of BLBC cell lines as well as in CSC-enriched populations. [Mol Cancer Res] Abstract

    Stem Cell Protein Piwil1 Endowed Endometrial Cancer Cells with Stem-Like Properties via Inducing Epithelial-Mesenchymal Transition
    Scientists suggest that stem cell protein Piwil1 plays important roles in regulating epithelial-mesenchymal transition and the acquisition of stem-like properties of endometrial cancer cells. [BMC Cancer] Full Article

    Salinomycin Promotes Anoikis and Decreases the CD44+/CD24 Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells
    Researchers investigated the effect of salinomycin on cell death, migration, and invasion, as well as cancer stem cell-like properties in MDA-MB-231 breast cancer cells. [PLoS One] Full Article

    Metformin and Soybean-Derived Bioactive Molecules Attenuate the Expansion of Stem Cell-Like Epithelial Subpopulation and Confer Apoptotic Sensitivity in Human Colon Cancer Cells
    To investigate the actions of metabolic regulators on cancer stem cell-like cells (CSC) in colorectal cancer, investigators determined the effects of soybean-derived bioactive molecules and the anti-diabetes drug metformin, alone and together, on the growth, survival, and frequency of CSC in human HCT116 cells. [Genes Nutr] Abstract

    Request your Free Wallchart on Naive and Primed Stem Cell States

    Tumorsphere as an Effective In Vitro Platform for Screening Anti-Cancer Stem Cell Drugs
    Tumorsphere cultivation is widely used to analyze the self-renewal capability of cancer stem cells (CSCs) and to enrich these cells from bulk cancer cells. This method also provides a reliable platform for screening potential anti-CSC agents. [Oncotarget] Full Article

    Visit our reviews page to see a complete list of reviews in the Cancer Stem Cell research field.

    Grants to Roswell Park Researchers in 3rd Quarter Total More than $7 Million
    Roswell Park Cancer Institute received more than $7.2 million in grant awards for important research projects during the third quarter of 2015. Two faculty members were awarded more than $2 million each for their respective investigations into the origins of the disease and cancer cell genesis. [Roswell Park Cancer Institute] Press Release

    TSRI Team Wins $1.8 Million to Study Early Events in Cancer Metastasis
    Scientists at The Scripps Research Institute (TSRI) have been awarded a grant of more than $1.8 million from the National Institutes of Health’s National Cancer Institute to investigate the molecular machinery involved in metastasis. [The Scripps Research Institute] Press Release

    MD Anderson’s Moon Shots Mission Grows to Confront Six More Cancer Types
    MD Anderson’s Moon Shots Program, an unprecedented effort and novel organizational model designed to more rapidly convert scientific discoveries into life-saving advances, has expanded its targets, adding several of the most intractable cancers to its campaign. [The University of Texas MD Anderson Cancer Center] Press Release

    From our sponsor: Learn how to form and isolate neural rosettes more efficiently. Watch the video.

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

    NEW Keystone Symposium – Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies
    January 24-28, 2016
    Vancouver, Canada

    Visit our events page to see a complete list of events in the Cancer Stem Cell community.

    NEW Postdoctoral Fellowship – Neural Development and Cancer (Columbia University)

    Group Leader Position – Cancer Research (Oslo University Hospital)

    PhD Studentships – Cancer Research (Cancer Research UK Manchester Institute)

    PhD Studentships – Cancer Research (University of Cambridge)

    Assistant, Associate or Full Professor – Hematopoietic Stem Cell Biology (Mayo Clinic)

    Research Technician II – Stem Cell and Gene Therapy (Fred Hutchinson Cancer Research Center)

    Postdoctoral Positions – Stem Cell, Developmental, and Cancer Biology (University of California Santa Cruz)

    Postdoctoral Positions – Stem Cell, Developmental, and Cancer Biology (Columbia University Medical Center)

    Assistant Professor – Stem Cell Biology (University of South Carolina)

    Postdoctoral Fellow – Cancer Biology (National Cancer Institute)

    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.


    Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Cancer Stem Cell News: Archives | Events | Contact Us